Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients
JAMA Internal Medicine · 01.12.2023 · 183 (12) · 1404
DOI: 10.1001/jamainternmed.2023.5099 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.12.2023. Verfasst von Kin Wah Fung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lister Hill National Center for Biomedical Communications, National Library of Medicine, Bethesda, Maryland. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This observational cohort study assesses the occurrence of post–COVID-19 condition symptoms in Medicare enrollees prescribed nirmatrelvir and molnupiravir.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lister Hill National Center for Biomedical Communications, National Library of Medicine, Bethesda, Maryland.
- National Institutes of Health, Bethesda, Maryland.
Zitieren
APA
Fung, K. W., Baye, F., Baik, S. H., & McDonald, C. J. (2023). Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients. JAMA Internal Medicine, 183(12), 1404. https://doi.org/10.1001/jamainternmed.2023.5099
Vancouver
Fung KW, Baye F, Baik SH, McDonald CJ. Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients. JAMA Internal Medicine. 2023;183(12):1404. doi:10.1001/jamainternmed.2023.5099
BibTeX
@article{Fung2023,
author = {Fung, Kin Wah and Baye, Fitsum and Baik, Seo H and McDonald, Clement J},
title = {Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients},
journal = {JAMA Internal Medicine},
year = {2023},
volume = {183},
number = {12},
pages = {1404},
doi = {10.1001/jamainternmed.2023.5099}
}
EUVIMED